You have 9 free searches left this month | for more free features.

liver-directed therapy

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Carcinoma, Hepatocellular, Liver Cell Carcinoma Trial in New Brunswick (Tislelizumab)

Recruiting
  • Carcinoma, Hepatocellular
  • Liver Cell Carcinoma
  • New Brunswick, New Jersey
  • +1 more
Sep 27, 2022

Metastatic Malignant Tumor in the Liver, Neuroendocrine Tumor Trial in San Francisco (procedure, biological, device)

Recruiting
  • Metastatic Malignant Neoplasm in the Liver
  • Neuroendocrine Neoplasm
  • Arterial Embolization
  • +3 more
  • San Francisco, California
    University of California, San Francisco
Dec 22, 2022

Surgery-Complications Trial in Villejuif (individualized GDFT, Restrictive fluid therapy strategy)

Recruiting
  • Surgery-Complications
  • individualized GDFT
  • Restrictive fluid therapy strategy
  • Villejuif, VAL DE Marne, France
    PAUL BROUSSE, centre hepato -biliaire
Jan 19, 2023

Liver Cancer Trial in Durham (Quality of life questionnaires)

Recruiting
  • Liver Cancer
  • Quality of life questionnaires
  • Durham, North Carolina
  • +1 more
Aug 10, 2022

Acetaminophen Exposure Trial in Denver (Acetaminophen)

Withdrawn
  • Acetaminophen Exposure
  • Denver, Colorado
    University of Colorado Denver
Aug 27, 2021

Hepatocellular Carcinoma, Cirrhosis, Liver Failure Trial in New Orleans (Branch Chain Amino Acid, maltodextrin)

Withdrawn
  • Hepatocellular Carcinoma
  • +2 more
  • Branch Chain Amino Acid
  • maltodextrin
  • New Orleans, Louisiana
    University Medical Center New Orleans
Jan 13, 2022

Liver Metastases Trial in Houston (Leucovorin, 5-FLUOROURACIL, Oxaliplatin)

Recruiting
  • Liver Metastases
  • Houston, Texas
    M D Anderson Cancer Center
Apr 26, 2022

Small-cell Lung Cancer Trial in New York (Carboplatin, Etoposide, Atezolizumab)

Recruiting
  • Small-cell Lung Cancer
  • New York, New York
    Columbia University Irving Medical Center, Herbert Irving Compre
Apr 7, 2022

Goal-directed Fluid Therapy on Postoperative Complications

Completed
  • Liver Diseases
  • Pancreas Disease
  • EV1000 platform
  • Seongnam, Gyeonggi, Korea, Republic of
    Seoul National University Bundang Hospital
Feb 21, 2022

Ventilator Lung, Liver Cirrhosis, Hepatocellular Carcinoma Trial in Seoul (conventional tidal volume (tidal volume [ml]= ideal

Not yet recruiting
  • Ventilator Lung
  • +3 more
  • conventional tidal volume (tidal volume [ml]= ideal body weight [kg]* 10~12) group
  • low tidal (tidal volume [ml]= ideal body weight [kg] * 6~8) volume
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Aug 3, 2022

Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Stage IV Liver Cancer Trial in Seattle (Computed Tomography, Single

Recruiting
  • Hepatocellular Carcinoma
  • +5 more
  • Computed Tomography
  • +2 more
  • Seattle, Washington
  • +1 more
Feb 24, 2022

Liver Diseases Trial (fresh frozen plasma, prothrombin complex concentrate)

Not yet recruiting
  • Liver Diseases
  • fresh frozen plasma
  • prothrombin complex concentrate
  • (no location specified)
Nov 16, 2023

Breast Cancer, Oligometastasis, Metastatic Breast Cancer Trial in Tokyo (Systemic therapy for 12 weeks after primary

Recruiting
  • Breast Cancer
  • +2 more
  • Systemic therapy for 12 weeks after primary registration
  • +3 more
  • Tokyo, Japan
    Tokyo Medical and Dental Univetsity
Nov 15, 2023

Breast Cancer, Metastatic Cancer, Metastatic Breast Cancer Trial in Cairo (radiation, procedure, other)

Recruiting
  • Breast Cancer
  • +2 more
  • Stereotactic Ablative Radiation Therapy
  • +2 more
  • Cairo, Egypt
    National Cancer Institute
Nov 20, 2023

Liver Carcinoma, Hepatic Cell Carcinoma Trial in Wuhan (CAR-GPC3 T cells)

Recruiting
  • Liver Carcinoma
  • Hepatic Cell Carcinoma
  • CAR-GPC3 T cells
  • Wuhan, Hubei, China
    Tao Zhang
Nov 20, 2023

Surgery Trial (Goal-directed therapy)

Not yet recruiting
  • Surgery
  • Goal-directed therapy
  • (no location specified)
Jul 19, 2023

Fluid Loss, Enhanced Recovery Trial in New Delhi (Goal directed Fluid Therapy, Conventional Fluid Therapy)

Recruiting
  • Fluid Loss
  • Enhanced Recovery
  • Goal directed Fluid Therapy
  • Conventional Fluid Therapy
  • New Delhi, Please Select, India
    Anita Kulkarni
Sep 6, 2023

Neuroendocrine Tumors, Gastrointestinal Tumors, Carcinoid Tumors Trial in Denver, Kansas City, Nashville (Lanreotide, Y-90

Terminated
  • Neuroendocrine Tumors
  • +2 more
  • Denver, Colorado
  • +2 more
Jul 5, 2022

Anesthesia, ERAS, Fluid Overload Trial (Goal-Directed Fluid Therapy guided by Inferior Vena Cava Collapsibility Index, standard

Not yet recruiting
  • Anesthesia
  • +3 more
  • Goal-Directed Fluid Therapy guided by Inferior Vena Cava Collapsibility Index
  • standard fluid management
  • (no location specified)
Nov 10, 2023

Kidney Injury, Acute Trial in Ghent (Early goal directed therapy during 6 hours after occurence of the early phase of acute

Withdrawn
  • Kidney Injury, Acute
  • Early goal directed therapy during 6 hours after occurence of the early phase of acute kidney injury
  • Ghent, Belgium
    University Hospital Ghent
Dec 15, 2022

Renal Injury, Acute Kidney Injury Trial (Goal Directed Fluid Therapy)

Not yet recruiting
  • Renal Injury
  • Acute Kidney Injury
  • Goal Directed Fluid Therapy
  • (no location specified)
Oct 25, 2023

Cushing Disease Trial (Fimepinostat)

Not yet recruiting
  • Cushing Disease
  • (no location specified)
Jul 31, 2023

Hypotension During Surgery Trial (Plasma-lyte, Norepinephrine)

Not yet recruiting
  • Hypotension During Surgery
  • (no location specified)
Oct 10, 2023

Pulmonary Embolism Trial in New York (Anticoagulant Therapy, Catheter-Directed Therapy)

Not yet recruiting
  • Pulmonary Embolism
  • Anticoagulant Therapy
  • Catheter-Directed Therapy
  • New York, New York
    NYU Langone Health - Tisch Hospital
Oct 18, 2022

(GDMT) Optimization and Adherence Longitudinal Study for Heart

Not yet recruiting
  • Heart Failure
    • Durham, North Carolina
    • +3 more
    Jun 7, 2023